The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbial systems are a black box. We created Microbial INtelligence Explorer to “MINE” their secrets• Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination•

Category: Women’s Health

Freya Biosciences Announces Positive Topline Clinical Trial Results for FB101 in Women with Asymptomatic Vaginal Dysbiosis
Clinical & Manufacturing

Freya Biosciences Announces Positive Topline Clinical Trial Results for FB101 in Women with Asymptomatic Vaginal Dysbiosis

JUN 28, 2023
Vaginal probiotics quietly making progress in drug reclassification in the EU
Biotics and Supplements

Vaginal probiotics quietly making progress in drug reclassification in the EU

MAY 23, 2023
Researchers identify potential approaches to modify the vaginal microbiome
Pharma & Human Health

Researchers identify potential approaches to modify the vaginal microbiome

MAR 30, 2022
Microbiome of mother’s vagina may affect infant mortality risk and baby’s development
Pharma & Human Health

Microbiome of mother’s vagina may affect infant mortality risk and baby’s development

FEB 4, 2022
Ferring, Rebiotix and MyBiotics Collaborate to Develop Microbiome Therapeutics in Reproductive Medicine and Maternal Health
Finance

Ferring, Rebiotix and MyBiotics Collaborate to Develop Microbiome Therapeutics in Reproductive Medicine and Maternal Health

FEB 19, 2021
‘Oral’ bacteria may disrupt the balance of the vaginal microbiome
Infectious Disease & AMR

‘Oral’ bacteria may disrupt the balance of the vaginal microbiome

SEP 1, 2020
Chr. Hansen acquires HSO Health Care to grow probiotics offering for women’s health
Biotics and Supplements

Chr. Hansen acquires HSO Health Care to grow probiotics offering for women’s health

APR 23, 2020
The Promise of probiotics for male sexual health
Biotics and Supplements

The Promise of probiotics for male sexual health

APR 1, 2020
VIRGO, The First Comprehensive Gene Catalog To Decode the Vaginal Microbiome
Pharma & Human Health

VIRGO, The First Comprehensive Gene Catalog To Decode the Vaginal Microbiome

FEB 28, 2020
Study provides first look at sperm microbiome using RNA sequencing
Pharma & Human Health

Study provides first look at sperm microbiome using RNA sequencing

JAN 31, 2020
Phage lysin stabilizes vaginal microbiome: Phagomed accelerates R&D program against bacterial vaginosis.
Pharma & Human Health

Phage lysin stabilizes vaginal microbiome: Phagomed accelerates R&D program against bacterial vaginosis.

OCT 23, 2019